88 results on '"Verhoeven, Rob H.A."'
Search Results
2. Assessing real-world representativeness of prospective registry cohorts in oncology: insights from patients with esophagogastric cancer
3. The association between hospital variation in curative treatment for esophagogastric cancer and health-related quality of life and survival
4. Gender differences in tumor characteristics, treatment and survival of colorectal cancer: A population-based study
5. Hospital practice variation in the proportion of patients with esophagogastric cancer discussed during an expert multidisciplinary team meeting
6. Late Toxicity and Health-Related Quality of Life Following Definitive Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis
7. Sex differences in treatment allocation and survival of potentially curable gastroesophageal cancer: A population-based study
8. Liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study
9. Managed Clinical Network for esophageal cancer enables reduction of variation between hospitals trends in treatment strategies, lead time, and 2-year survival
10. Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study
11. A population-based study on treatment and outcomes in patients with gastric adenocarcinoma diagnosed with distant interval metastases
12. The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study
13. Implementation of a regional video multidisciplinary team meeting is associated with an improved prognosis for patients with oesophageal cancer A mixed methods approach
14. Temporal improvements noted in life expectancy of patients with colorectal cancer; a Dutch population-based study
15. Clinical, Pathology, Genetic, and Molecular Features of Colorectal Tumors in Adolescents and Adults 25 Years or Younger
16. Long-term Survival After Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Propensity-score Matched Analysis
17. Long-Term Oncological Outcomes After Colorectal Anastomotic Leakage: A Retrospective Dutch Population-based Study
18. Refraining from resection in patients with potentially curable gastric carcinoma
19. Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer
20. Should jaundice preclude resection in patients with gallbladder cancer? Results from a nation-wide cohort study
21. Poor compliance with perioperative chemotherapy for resectable gastric cancer and its impact on survival
22. Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer—Results of a nationwide population-based study
23. The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer.
24. Modest improvement in 20 years of kidney cancer care in the Netherlands
25. Variation in cancer incidence in northeastern Belgium and southeastern Netherlands seems unrelated to cadmium emission of zinc smelters
26. Gastric cancer incidence and mortality trends 2007-2016 in three European countries.
27. Survival trends of patients with non‐metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates.
28. Association between Surgical Patient Selection and Hospital Variation in Failure to Cure in Esophageal Cancer Surgery: A Nationwide Cohort Study.
29. Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer
30. Effect of surgical margin status after radical prostatectomy on health-related quality of life and illness perception in patients with prostate cancer
31. Treatment patterns and survival in advanced unresectable esophageal squamous cell cancer: A population‐based study.
32. A population-based study in resected esophageal or gastroesophageal junction cancer aligned with CheckMate 577.
33. Prognosis of Interval Distant Metastases After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
34. Incidence trends and survival of penile squamous cell carcinoma in the Netherlands
35. Follow‐up practice and healthcare utilisation of colorectal cancer survivors.
36. Largely varying patterns and trends of primary cancer-directed resection for gastric carcinoma with synchronous distant metastasis in Europe and the US: a population-based study calling for further standardization of care.
37. Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: A population-based study.
38. From presentation to paper: Gender disparities in oncological research.
39. Neoadjuvant Chemotherapy for Locally Advanced T4 Colon Cancer: A Nationwide Propensity-Score Matched Cohort Analysis.
40. Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real‐world evidence study.
41. Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study.
42. The Metastatic Pattern of Intestinal and Diffuse Type Gastric Adenocarcinoma – A Dutch National Cohort Study.
43. An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients.
44. Clinical lymph node staging in colorectal cancer; a flip of the coin?
45. Role of neoadjuvant chemoradiotherapy in clinical T2N0M0 esophageal cancer: A population-based cohort study.
46. Presence and Number of Positive Surgical Margins after Radical Prostatectomy for Prostate Cancer: Effect on Oncological Outcome in a Population-Based Cohort.
47. Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease.
48. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin.
49. Adrenocortical carcinoma: A population-based study on incidence and survival in the Netherlands since 1993.
50. Incidence and Survival Trends of Uncommon Corpus Uteri Malignancies in the Netherlands, 1989-2008.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.